FDA Inspection
AX Pharmaceutical CorporationAX Pharmaceutical Corporation – FDA Inspection, May 6, 2022
Record Details
This FDA Inspection record concerns AX Pharmaceutical Corporation, with an inspection on May 6, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- May 6, 2022
- Product Type
- Drugs
View Company Profile
ID · ed40eb38-a050-47af-b183-99b67ff693e9
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1169095
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of AX Pharmaceutical Corporation
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 5, 2024 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| September 1, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 20, 2016 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for AX Pharmaceutical Corporation
- FDA Inspection 1236258 - 2024-03-05
- FDA Inspection 1027810 - 2017-09-01
- FDA Inspection 973398 - 2016-05-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.